{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:51:32Z","timestamp":1772347892148,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1136\/ard.2007.081679","type":"journal-article","created":{"date-parts":[[2007,11,24]],"date-time":"2007-11-24T01:33:49Z","timestamp":1195868029000},"page":"880-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis"],"prefix":"10.1016","volume":"67","author":[{"given":"X","family":"Pu\u00c3\u00a9chal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Miceli-Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Mejjad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Lafforgue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Solau-Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Steinfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Villoutreix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Tr\u00c3\u00a8ves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.081679_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005792-198611000-00002","article-title":"Rheumatoid vasculitis: survival and associated risk factors.","volume":"65","author":"Vollertsen","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2007.081679_bib2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis: a clinicopathological and prognostic study of 32 patients.","volume":"38","author":"Pu\u00c3\u00a9chal","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081679_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.1780390213","article-title":"The mortality of rheumatoid vasculitis compared with rheumatoid arthritis.","volume":"39","author":"Voskuyl","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081679_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/ard.56.1.41","article-title":"ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis.","volume":"56","author":"Flipo","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081679_bib5","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.22208","article-title":"Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.","volume":"54","author":"Matsunawa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081679_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2007.081679_bib7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/rheumatology\/39.12.1436","article-title":"Mononeuritis secondary to rheumatoid arthritis responds to etanercept.","volume":"39","author":"Richter","year":"2000","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2007.081679_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/41.2.234","article-title":"Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab.","volume":"41","author":"Garcia-Porrua","year":"2002","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2007.081679_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.62.6.587","article-title":"Successful treatment of severe rheumatoid vasculitis by infliximab.","volume":"62","author":"Unger","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081679_bib10","first-page":"759","article-title":"Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab.","volume":"32","author":"Armstrong","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081679_bib11","first-page":"1607","article-title":"Rheumatoid vasculitis treated with infliximab.","volume":"32","author":"van der Bijl","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081679_bib12","first-page":"433","article-title":"Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?","volume":"33","author":"Garcia-Porrua","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081679_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081679_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.081679_bib15","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724437230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724437230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.081679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:28:48Z","timestamp":1737264528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724437230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0003496724437230"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.081679","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.081679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}